Klebsiella purified polyvalent bacteriophage
Bacteriophages
Description
The preparation causes specific lysis of bacteria Klebsiella pneumoniae, Klebsiella ozaenae, Klebsiella rhinoscleromatis.
Presentation
Solution for oral, local and external administration, 10 ml or 20 ml vials. 4 or 10 vials in each cardboard package with a package insert. 4 vials in each PVC blister. 1 PVC blister in each cardboard package with a package insert.
Ingredients
The preparation is a sterile mixture of purified filtrates of phage lysates of Klebsiella pneumoniae, Klebsiella ozaenae, Klebsiella rhinoscleromatis.
Excipient:
- preservative – 8-hydroxyquinoline sulfate monohydrate - 0.0001 g/ml (equal to 8-hydroxyquinoline sulfate, estimated content).
Indications
Treatment and prevention of diseases caused by Klebsiella pneumoniae, Klebsiella ozaenae, Klebsiella rhinoscleromatis as part of the complex therapy:
- atrophic rhinitis, scleroma;
- disease of the gastrointestinal tract (gastroenterocolitis, cholecystitis, pancreatitis, intestinal disbacteriosis);
- inflammatory diseases of infants and young children (gastroenterocolitis, intestinal disbacteriosis, omphalitis, pemphigus, pyoderma, septicemia and pyosepticemia of varios localization);
- surgical infections (festering wounds, purulent skin lesions, burns, peritonitis, pleurisy, mastitis, osteomyelitis, abscess);
- urogenital infections (cystitis, pyelonephritis, urethritis, endometritis, vulvitis, bartholinitis, colpitis, salpingo-oophoritis);
- purulent-inflammatory diseases of the ear, nose, sinuses, oral cavity, pharynx, larynx, bronchi, lungs and pleura (otitis, tonsillitis, pharyngitis, laryngitis, stomatitis, periodontal disease, sinusitis, sinusitis, bronchitis, pneumonia, pleurisy);
- post-traumatic conjunctivitis, keratoconjunctivitis, corneal ulcers and purulent iridocyclitis;
- prevention of hospital-acquired infections caused by Klebsiella.
An important condition for the effective phage therapy is a preliminary determination of the phage sensitivity of the pathogen.